GAURI R VARADHACHARY to Administration, Oral
This is a "connection" page, showing publications GAURI R VARADHACHARY has written about Administration, Oral.
Connection Strength
0.044
-
Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors. Cancer Invest. 2008 Oct; 26(8):794-9.
Score: 0.015
-
Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors. Invest New Drugs. 2008 Oct; 26(5):445-54.
Score: 0.015
-
Phase I trial of oral talactoferrin alfa in refractory solid tumors. Invest New Drugs. 2006 May; 24(3):233-40.
Score: 0.013